Artículos del autor

solaci

Coronary Disease

TCT 2021 | SUGAR Trial: Polymer-Free Stent in Diabetes

In CAD patients with diabetes the polymer-free amphilimus-eluting stent resulted non-inferior to the polymer-based zotarolimus-eluting Resolute Onyx. This...
solaci -
Antithrombotic Anticoagulants

Atrial Fibrillation and Dementia: Which Anticoagulant Agent Presents the Lowest Risk?

Atrial fibrillation is a risk factor for dementia and anticoagulant agents have been proven to decrease it....
solaci -
International Congresses

TCT 2021

Here are the most important scientific articles of the TCT 2021 Congress. If you cannot view the articles,...
solaci -
Institutional News

Nov 12 & Nov 13 – 2° Interventional Cardiology Regional Course SOPHIE – SOLACI

solaci -
Institutional News

The Most Read Articles in Interventional Cardiology in October

01- ISCHEMIA: Prognosis is Determined by Anatomy, not Functionality The ISCHEMIA study keeps providing scientific news. This work in patients...
solaci -
Antithrombotic Anticoagulants

AFIRE Trial: Atrial Fibrillation and PCI. What is the Ideal Therapy?

Patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI) will benefit from rivaroxaban monotherapy both in terms...
solaci -
Structural heart disease

Is Troponin Elevation After TAVR Related to Mortality?

Troponins have long had diagnostic value not only for infarction. Their ability to predict mortality is well...
solaci -
Institutional News

Webinar SOLACI-CACI@MIL – “He for She” Campaign: When Equal Opportunity in Interventional Cardiology Depends on Everyone: The Perspective of the Latin American Interventional Women...

solaci -